Search - tctmd.com

Displaying 241 - 260 of 260

Sort: Relevancy | Date

Presentation TCT 2016

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Presenter: Bernard J. Gersh, Harry Rakowski, Michael A. Fifer

October 30, 2016

News Daily News

La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular

Michael O'Riordan

October 18, 2016

News Daily News

AHA 提供他汀类药物和心血管药物药物相互作用指导

Michael O'Riordan

October 18, 2016

News Daily News

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

Michael O'Riordan

October 18, 2016

News Daily News

FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm

Michael O'Riordan

October 11, 2016

News Daily News

Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation

Michael O'Riordan

October 07, 2016

News Daily News

Postmortem Examination of Pacemakers and Defibrillators Provides Useful Clinical Clues

L.A. McKeown

September 12, 2016

News Conference News ESC 2016

NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry

Michael O'Riordan

August 28, 2016

News Conference News ESC 2016

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

Michael O'Riordan

August 28, 2016

News Daily News

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

Michael O'Riordan

August 24, 2016

News Daily News

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Michael O'Riordan

August 18, 2016

News Daily News

Study Provides More Evidence That Having A-fib Ups Risk of Developing Dementia

L.A. McKeown

July 19, 2016

News Daily News

New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care

Michael O'Riordan

June 29, 2016

News Daily News

Black Individuals Have Less A-fib, but When They Do, the Consequences Are More Dire

Michael O'Riordan

June 24, 2016

News Daily News

止泻药洛哌丁胺的滥用与严重心脏事件包括死亡相关

Michael O'Riordan

June 08, 2016

News Daily News

Serious Cardiac Events, Including Death, Linked to Abuse of Antidiarrheal Medication Loperamide

Michael O'Riordan

June 08, 2016

News Daily News

Los Episodios Cardíacos Serios, incluida la Muerte se asocian a un Abuso del Fármaco Antidiarréico Lorepamida

Michael O'Riordan

June 08, 2016

News Daily News

Publica la AHA declaración sobre los desfibriladores portátiles y advierte que los datos sobre su eficacia son limitados

Michael O'Riordan

March 31, 2016

News Daily News

AHA 发表声明警告称可穿戴除颤仪的有效性数据尚不充分

Michael O'Riordan

March 31, 2016

News Daily News

AHA Issues Statement on Wearable Defibrillators, Cautions That Effectiveness Data Are Limited

Michael O'Riordan

March 31, 2016

Advertisement

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular

AHA 提供他汀类药物和心血管药物药物相互作用指导

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm

Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation

Postmortem Examination of Pacemakers and Defibrillators Provides Useful Clinical Clues

NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Study Provides More Evidence That Having A-fib Ups Risk of Developing Dementia

New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care

Black Individuals Have Less A-fib, but When They Do, the Consequences Are More Dire

止泻药洛哌丁胺的滥用与严重心脏事件包括死亡相关

Serious Cardiac Events, Including Death, Linked to Abuse of Antidiarrheal Medication Loperamide

Los Episodios Cardíacos Serios, incluida la Muerte se asocian a un Abuso del Fármaco Antidiarréico Lorepamida

Publica la AHA declaración sobre los desfibriladores portátiles y advierte que los datos sobre su eficacia son limitados

AHA 发表声明警告称可穿戴除颤仪的有效性数据尚不充分

AHA Issues Statement on Wearable Defibrillators, Cautions That Effectiveness Data Are Limited

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content